Entera Bio files legal opinion exhibit, no material business update

Entera Bio Ltd.

Filing solely to submit Exhibit 5.1 (legal opinion of Herzog Fox & Neeman) and Exhibit 23.1 (consent).
No financial results, operational milestones, or guidance changes reported.
The warrant exercise price of $5.85 per ordinary share is unchanged.

item 9.01

Entera Bio Ltd. filing history →

Source: SEC EDGAR

accession 0001178913-25-000080

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.